Enantiomer analysis of a new street drug, 3,4-methylenedioxy-N-methyl-butanamine, in rat urine

Journal of Analytical Toxicology

Volumn 26, Issue 2, 2002, Pages 104-109

  Nagai, Toshiaki ^a   Matsushima, Kazumi ^a,b   Suzuki, Atsuko ^a   Saotome, Atsuko ^a   Kurosu, Akira ^a   Nihei, Hirohisa ^a,b   Kuroyanagi, Kazumi ^c   Tokudome, Shogo ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b Tochigi Pref Police HQ   (Japan)

^c Tokyo Medical Examiner's Office   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXY N METHYLBUTANAMINE; 3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; METHAMPHETAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHIRALITY; DEMETHYLATION; DRUG DETERMINATION; DRUG DISPOSITION; DRUG EXCRETION; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RAT; STEREOCHEMISTRY; URINALYSIS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0036186849     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/26.2.104     Document Type: Article

References (24)

1. Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: Representatives of a novel therapeutic class
2. Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: Entactogens
3. Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues
4. 3H-Monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues
5. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration
6. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists
7. Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration
8. Epidemiology of designer drug use in Spain
9. Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users
10. Identification of 3,4-methylenedioxyamphetamine analogs encountered in clandestine tablets
11. N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine, a representative of a new class of street drugs
12. ’Eve’ and ’ecstacy’, a report of five deaths associated with the use of MDEA and MDMA
13. On the metabolism and the toxicological analysis of methylenedioxyalkylamine designer drugs by gas chromatography-mass spectrometry
14. Methods for the analysis of 1-(3,4-methylenedioxyphenyl)-2-butanamine and N-methyl-1-(3,4-methylenedioxyphenyl)-2-propanamine (MDMA)
15. Immunoassay responses of MBDB
16. Optical isomer analysis of 3,4-methylenedioxyamphetamine analogues and their stereoselective disposition in rats
17. The metabolic fate of amphetamine in man and other species
18. Simultaneous HPLC analysis of optical isomers of methamphetamine and its metabolites, and stereoselective metabolism of racemic methamphetamine in rat urine
19. Analysis of time-lapse of d- and l-enantiomers of racemic ethylamphetamine and stereoselective metabolism in rat urine by HPLC determination
20. Further investigation of the discriminative stimulants properties of MDA
21. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity
22. New variety of street drugs poses growing problem
23. Neurometabolic effects of psilocybin, 3,4-methylene-dioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG